N/A
Manufactured by Allegiant Health
13 FDA adverse event reports analyzed
Last updated: 2026-04-14
CHILDRENS ALLERGY RELIEF is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Allegiant Health. The most commonly reported adverse reactions for CHILDRENS ALLERGY RELIEF include AGGRESSION, COVID-19, ERYTHEMA, FULL BLOOD COUNT ABNORMAL, HAEMOGLOBIN DECREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHILDRENS ALLERGY RELIEF.
Out of 6 classified reports for CHILDRENS ALLERGY RELIEF:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 13 FDA FAERS reports that mention CHILDRENS ALLERGY RELIEF. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include AGGRESSION, COVID-19, ERYTHEMA, FULL BLOOD COUNT ABNORMAL, HAEMOGLOBIN DECREASED, INFECTION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Allegiant Health in connection with CHILDRENS ALLERGY RELIEF. Always verify the specific product and NDC with your pharmacist.